European Healthcare Acquisition & Growth Company B.V. Stock

Equities

EHCS

NL0015000K10

Investment Holding Companies

Market Closed - Euronext Amsterdam 11:11:01 2024-04-12 EDT 5-day change 1st Jan Change
9.15 EUR 0.00% Intraday chart for European Healthcare Acquisition & Growth Company B.V. 0.00% -8.50%

Financials

Sales 2022 - Sales 2023 - Capitalization 200M 187M 273M
Net income 2022 -30M -28.06M -41.01M Net income 2023 26M 24.32M 35.54M EV / Sales 2022 -
Net cash position 2022 204M 191M 279M Net cash position 2023 13.9M 13M 19M EV / Sales 2023 -
P/E ratio 2022
-2.2 x
P/E ratio 2023
13.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 11.32%
More Fundamentals * Assessed data
Dynamic Chart
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
European Healthcare Acquisition & Growth Shareholders Back Extension of Business Combination Deadline MT
Tranche Update on European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback Plan announced on October 4, 2023. CI
European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback announced on October 4, 2023, has expired with 18,761,038 shares, representing 93.8% for ?190.8 million. CI
European Healthcare Acquisition & Growth Proposes Extension to Merger Completion Deadline MT
European Healthcare Acquisition & Growth Company B.V. announces an Equity Buyback. CI
European Healthcare Acquisition & Growth Company B.V. authorizes a Buyback Plan. CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
European Healthcare Acquisition & Growth to Propose Extension to Business Combination Deadline MT
European Healthcare Acquisition & Growth, Croma-Pharma Cancel Merger Talks MT
CROMA-PHARMA GmbH cancelled the acquisition of European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
European Healthcare Acquisition & Growth Drops Croma-Pharma Merger from General Meeting Agenda MT
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Healthcare Acquisition & Growth Company B.V. Auditor Raises 'Going Concern' Doubt CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
6 months-9.41%
Current year-8.50%
More quotes
1 week
9.15
Extreme 9.15
9.15
1 month
9.15
Extreme 9.15
9.20
Current year
9.15
Extreme 9.15
10.00
1 year
9.00
Extreme 9
10.50
3 years
9.00
Extreme 9
11.00
5 years
9.00
Extreme 9
11.00
10 years
9.00
Extreme 9
11.00
More quotes
Date Price Change Volume
24-04-26 9.15 0.00% 0
24-04-25 9.15 0.00% 0
24-04-24 9.15 0.00% 0
24-04-23 9.15 0.00% 0
24-04-22 9.15 0.00% 0

Real-time Euronext Amsterdam, April 12, 2024 at 11:11 am

More quotes
European Healthcare Acquisition & Growth Company B.V. is a Special Purpose Acquisition Company (SPAC) aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.
More about the company